Search Results - Ara A Vaporciyan

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy

    Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy by Apar Pataer, Ruping Shao, Arlene M. Correa, Carmen Behrens, Jack A. Roth, Ara A. Vaporciyan, Ignacio I. Wistuba, Stephen G. Swisher

    Published 2018-06-01

    Abstract In a previous study, we determined that major pathologic response (MPR) as indicated by the percentage of residual viable tumor cells predicted overall survival (OS) in patients with non‐small‐cell lung cancer (NSCLC) who received neoadjuvant chemotherapy. In this study, we assessed whether...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer

    Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer by Jing Wang, Ignacio I Wistuba, Alexandre Reuben, Chantale Bernatchez, Tina Cascone, Jianjun Zhang, Boris Sepesi, Ara A Vaporciyan, Marcelo V Negrao, Hai T Tran, Lorenzo Federico, Mara B Antonoff, Stephen G Swisher, John V Heymach, Don L Gibbons, Cara L Haymaker, Lauren Byers, Edwin Parra, Younghee Lee, Daniel J McGrail, Nathaniel Deboever, Kyle G. Mitchell

    Published 2025-06-01

    Tumor-initiated emergency granulopoiesis results in expansion of the circulating neutrophil compartment and neutrophil recruitment into the tumor microenvironment (TME), which may in turn promote tumor progression. Although an elevated circulating neutrophil-to-lymphocyte ratio (cNLR) has repeatedly...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: